Home / Stocks / IMMX

IMMX insider trading

Immix Biopharma, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
7
Bought · 24 mo
$135k
Buys · last 90 days
0 · $0
Most recent buy
2025-12-10

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-12-10Rachman Ilya M
CEO and Chairman
Bought746$6.67$5k
2025-12-10Morris Gabriel S
CFO
Bought770$6.58$5k
2025-09-17Morris Gabriel S
CFO
Bought2,600$1.97$5k
2025-09-17Rachman Ilya M
CEO and Chairman
Bought2,500$2.02$5k
2025-06-20Rachman Ilya M
CEO and Chairman
Bought2,178$2.30$5k
2025-06-20Morris Gabriel S
CFO
Bought2,225$2.28$5k
2024-12-26Hsu Jason
Director
Bought47,700$2.19$104k

Most active insider buyers

InsiderRoleBuysTotal bought
Hsu JasonDirector1$104k
Morris Gabriel SCFO3$15k
Rachman Ilya MCEO and Chairman3$15k

See IMMX on the chart

Every insider buy and sell for IMMX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.